Van der Valk M - Search Results

1

Optimising HIV care using information obtained from PROMs: protocol for an observational study.

Moody K, Nieuwkerk PT, Bedert M, Nellen JF, Weijsenfeld A, Sigaloff KCE, Laan L, Bruins C, van Oers H, Haverman L, Geerlings SE, Van der Valk M. Moody K, et al. Among authors: van oers h, van der valk m. BMJ Open. 2023 Nov 27;13(11):e073758. doi: 10.1136/bmjopen-2023-073758. BMJ Open. 2023. PMID: 38011973 Free PMC article.

2

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.

Kesselring AM, Wit FW, Sabin CA, Lundgren JD, Gill MJ, Gatell JM, Rauch A, Montaner JS, de Wolf F, Reiss P, Mocroft A; Nevirapine Toxicity Multicohort Collaboration. Kesselring AM, et al. AIDS. 2009 Aug 24;23(13):1689-99. doi: 10.1097/QAD.0b013e32832d3b54. AIDS. 2009. PMID: 19487907

3

Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands.

Gras L, Jurriaans S, Bakker M, van Sighem A, Bezemer D, Fraser C, Lange J, Prins JM, Berkhout B, de Wolf F; ATHENA National Observational Cohort Study. Gras L, et al. PLoS One. 2009 Oct 7;4(10):e7365. doi: 10.1371/journal.pone.0007365. PLoS One. 2009. PMID: 19809510 Free PMC article.

4

Reduction of the door-to-needle time for administration of antibiotics in patients with a severe infection: a tailored intervention project.

van Tuijn CF, Luitse JS, van der Valk M, van Wissen S, Prins M, Rosmulder R, Geerlings SE. van Tuijn CF, et al. Among authors: van wissen s, van der valk m. Neth J Med. 2010 Mar;68(3):123-7. Neth J Med. 2010. PMID: 20308707 Free article.

5

Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals.

van Sighem AI, Gras LA, Reiss P, Brinkman K, de Wolf F; ATHENA national observational cohort study. van Sighem AI, et al. AIDS. 2010 Jun 19;24(10):1527-35. doi: 10.1097/QAD.0b013e32833a3946. AIDS. 2010. PMID: 20467289

6

An unexpected cause of multiple intra-abdominal abscesses in an HIV-positive patient.

van der Spek AH, Vosters JL, Visser CE, van der Valk M, Nellen JF. van der Spek AH, et al. Among authors: van der valk m. Neth J Med. 2012 May;70(4):190-2. Neth J Med. 2012. PMID: 22641627 Free article.

7

Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individuals.

Gras L, de Wolf F, Smit C, Prins M, van der Meer JT, Vanhommerig JW, Zwinderman AH, Schinkel J, Geskus RB; ATHENA national observational cohort and the MOSAIC study. Gras L, et al. J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):536-42. doi: 10.1097/QAI.0000000000000514. J Acquir Immune Defic Syndr. 2015. PMID: 25559595

8

Diminished impact of ethnicity as a risk factor for chronic kidney disease in the current HIV treatment era.

Schoffelen AF, Smit C, van Lelyveld SF, Vogt L, Bauer MP, Reiss P, Hoepelman AI, Barth RE; ATHENA National Observational HIV Cohort. Schoffelen AF, et al. J Infect Dis. 2015 Jul 15;212(2):264-74. doi: 10.1093/infdis/jiv026. Epub 2015 Jan 18. J Infect Dis. 2015. PMID: 25601941

9

Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.

Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA; HIV-CAUSAL Collaboration. Lodi S, et al. Lancet HIV. 2015 Aug;2(8):e335-43. doi: 10.1016/S2352-3018(15)00108-3. Epub 2015 Jul 7. Lancet HIV. 2015. PMID: 26423376 Free PMC article.

10

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.

Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study. Mocroft A, et al. Lancet HIV. 2016 Jan;3(1):e23-32. doi: 10.1016/S2352-3018(15)00211-8. Epub 2015 Nov 17. Lancet HIV. 2016. PMID: 26762990 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters